Physician profile
Amy Higgins
NPI 1528315207
$1,004.99
in general payments reported to CMS, 2019-2025
16 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.59 · 2022: $310 · 2023: $202 · 2024: $194 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $345.15 | 2021-2024 | Azstarys |
| Genentech USA, INC. | $113.07 | 2022 | |
| Sanofi Pasteur INC. | $74.47 | 2021-2025 | |
| Kaleo, INC. | $71.77 | 2022-2024 | Auvi-Q |
| Cranial Technologies, INC | $68.71 | 2022-2025 | Doc Band |
| Pfizer INC. | $55.34 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $48.83 | 2023-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Tris Pharma INC | $39.98 | 2022-2023 | Dyanavel Xr |
| Ars Pharmaceuticals Operations, INC. | $39.00 | 2025 | Neffy |
| Sobi, INC | $33.67 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $29.95 | 2025 | Qelbree |
| Seqirus USA INC | $21.92 | 2025 | Flucelvax |
| Collegium Pharmaceutical, INC. | $19.30 | 2025 | Jornay Pm |
| Lilly USA, LLC | $17.02 | 2025 | Mounjaro, Zepbound |
| Ironshore Pharmaceuticals INC. | $13.89 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.